Global Enteric Disease Testing and Therapeutic Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Enteric Disease Testing and Therapeutic market size was valued at USD 3101.6 million in 2023 and is forecast to a readjusted size of USD 3408.4 million by 2030 with a CAGR of 1.4% during review period.
Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is increasing the prevalence of enteric diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Enteric Disease Testing and Therapeutic industry chain, the market status of Hospital (Bacterial Disease, Viral Disease), Specialty Clinic (Bacterial Disease, Viral Disease), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Enteric Disease Testing and Therapeutic.
Regionally, the report analyzes the Enteric Disease Testing and Therapeutic markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Enteric Disease Testing and Therapeutic market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Enteric Disease Testing and Therapeutic market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Enteric Disease Testing and Therapeutic industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Bacterial Disease, Viral Disease).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Enteric Disease Testing and Therapeutic market.
Regional Analysis: The report involves examining the Enteric Disease Testing and Therapeutic market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Enteric Disease Testing and Therapeutic market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Enteric Disease Testing and Therapeutic:
Company Analysis: Report covers individual Enteric Disease Testing and Therapeutic players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Enteric Disease Testing and Therapeutic This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Specialty Clinic).
Technology Analysis: Report covers specific technologies relevant to Enteric Disease Testing and Therapeutic. It assesses the current state, advancements, and potential future developments in Enteric Disease Testing and Therapeutic areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Enteric Disease Testing and Therapeutic market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Enteric Disease Testing and Therapeutic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Enteric Disease Testing and Therapeutic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Enteric Disease Testing and Therapeutic, with revenue, gross margin and global market share of Enteric Disease Testing and Therapeutic from 2019 to 2024.
Chapter 3, the Enteric Disease Testing and Therapeutic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Enteric Disease Testing and Therapeutic market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Enteric Disease Testing and Therapeutic.
Chapter 13, to describe Enteric Disease Testing and Therapeutic research findings and conclusion.
Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is increasing the prevalence of enteric diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Enteric Disease Testing and Therapeutic industry chain, the market status of Hospital (Bacterial Disease, Viral Disease), Specialty Clinic (Bacterial Disease, Viral Disease), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Enteric Disease Testing and Therapeutic.
Regionally, the report analyzes the Enteric Disease Testing and Therapeutic markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Enteric Disease Testing and Therapeutic market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Enteric Disease Testing and Therapeutic market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Enteric Disease Testing and Therapeutic industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Bacterial Disease, Viral Disease).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Enteric Disease Testing and Therapeutic market.
Regional Analysis: The report involves examining the Enteric Disease Testing and Therapeutic market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Enteric Disease Testing and Therapeutic market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Enteric Disease Testing and Therapeutic:
Company Analysis: Report covers individual Enteric Disease Testing and Therapeutic players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Enteric Disease Testing and Therapeutic This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Specialty Clinic).
Technology Analysis: Report covers specific technologies relevant to Enteric Disease Testing and Therapeutic. It assesses the current state, advancements, and potential future developments in Enteric Disease Testing and Therapeutic areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Enteric Disease Testing and Therapeutic market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Enteric Disease Testing and Therapeutic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Bacterial Disease
- Viral Disease
- Parasitic Disease
- Hospital
- Specialty Clinic
- Others
- Abbott
- GlaxoSmithKline
- Becton Dickinson
- bioMйrieux
- Sanofi
- Bayer Pharma
- Bio-Rad
- Quest Diagnostics
- Trinity Biotech
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Enteric Disease Testing and Therapeutic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Enteric Disease Testing and Therapeutic, with revenue, gross margin and global market share of Enteric Disease Testing and Therapeutic from 2019 to 2024.
Chapter 3, the Enteric Disease Testing and Therapeutic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Enteric Disease Testing and Therapeutic market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Enteric Disease Testing and Therapeutic.
Chapter 13, to describe Enteric Disease Testing and Therapeutic research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Enteric Disease Testing and Therapeutic
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Enteric Disease Testing and Therapeutic by Type
1.3.1 Overview: Global Enteric Disease Testing and Therapeutic Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Enteric Disease Testing and Therapeutic Consumption Value Market Share by Type in 2023
1.3.3 Bacterial Disease
1.3.4 Viral Disease
1.3.5 Parasitic Disease
1.4 Global Enteric Disease Testing and Therapeutic Market by Application
1.4.1 Overview: Global Enteric Disease Testing and Therapeutic Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Specialty Clinic
1.4.4 Others
1.5 Global Enteric Disease Testing and Therapeutic Market Size & Forecast
1.6 Global Enteric Disease Testing and Therapeutic Market Size and Forecast by Region
1.6.1 Global Enteric Disease Testing and Therapeutic Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Enteric Disease Testing and Therapeutic Market Size by Region, (2019-2030)
1.6.3 North America Enteric Disease Testing and Therapeutic Market Size and Prospect (2019-2030)
1.6.4 Europe Enteric Disease Testing and Therapeutic Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size and Prospect (2019-2030)
1.6.6 South America Enteric Disease Testing and Therapeutic Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Enteric Disease Testing and Therapeutic Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Enteric Disease Testing and Therapeutic Product and Solutions
2.1.4 Abbott Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbott Recent Developments and Future Plans
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Enteric Disease Testing and Therapeutic Product and Solutions
2.2.4 GlaxoSmithKline Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GlaxoSmithKline Recent Developments and Future Plans
2.3 Becton Dickinson
2.3.1 Becton Dickinson Details
2.3.2 Becton Dickinson Major Business
2.3.3 Becton Dickinson Enteric Disease Testing and Therapeutic Product and Solutions
2.3.4 Becton Dickinson Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Becton Dickinson Recent Developments and Future Plans
2.4 bioMйrieux
2.4.1 bioMйrieux Details
2.4.2 bioMйrieux Major Business
2.4.3 bioMйrieux Enteric Disease Testing and Therapeutic Product and Solutions
2.4.4 bioMйrieux Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 bioMйrieux Recent Developments and Future Plans
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Enteric Disease Testing and Therapeutic Product and Solutions
2.5.4 Sanofi Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sanofi Recent Developments and Future Plans
2.6 Bayer Pharma
2.6.1 Bayer Pharma Details
2.6.2 Bayer Pharma Major Business
2.6.3 Bayer Pharma Enteric Disease Testing and Therapeutic Product and Solutions
2.6.4 Bayer Pharma Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bayer Pharma Recent Developments and Future Plans
2.7 Bio-Rad
2.7.1 Bio-Rad Details
2.7.2 Bio-Rad Major Business
2.7.3 Bio-Rad Enteric Disease Testing and Therapeutic Product and Solutions
2.7.4 Bio-Rad Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Bio-Rad Recent Developments and Future Plans
2.8 Quest Diagnostics
2.8.1 Quest Diagnostics Details
2.8.2 Quest Diagnostics Major Business
2.8.3 Quest Diagnostics Enteric Disease Testing and Therapeutic Product and Solutions
2.8.4 Quest Diagnostics Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Quest Diagnostics Recent Developments and Future Plans
2.9 Trinity Biotech
2.9.1 Trinity Biotech Details
2.9.2 Trinity Biotech Major Business
2.9.3 Trinity Biotech Enteric Disease Testing and Therapeutic Product and Solutions
2.9.4 Trinity Biotech Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Trinity Biotech Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Enteric Disease Testing and Therapeutic Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Enteric Disease Testing and Therapeutic by Company Revenue
3.2.2 Top 3 Enteric Disease Testing and Therapeutic Players Market Share in 2023
3.2.3 Top 6 Enteric Disease Testing and Therapeutic Players Market Share in 2023
3.3 Enteric Disease Testing and Therapeutic Market: Overall Company Footprint Analysis
3.3.1 Enteric Disease Testing and Therapeutic Market: Region Footprint
3.3.2 Enteric Disease Testing and Therapeutic Market: Company Product Type Footprint
3.3.3 Enteric Disease Testing and Therapeutic Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Enteric Disease Testing and Therapeutic Consumption Value and Market Share by Type (2019-2024)
4.2 Global Enteric Disease Testing and Therapeutic Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Enteric Disease Testing and Therapeutic Consumption Value Market Share by Application (2019-2024)
5.2 Global Enteric Disease Testing and Therapeutic Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Enteric Disease Testing and Therapeutic Consumption Value by Type (2019-2030)
6.2 North America Enteric Disease Testing and Therapeutic Consumption Value by Application (2019-2030)
6.3 North America Enteric Disease Testing and Therapeutic Market Size by Country
6.3.1 North America Enteric Disease Testing and Therapeutic Consumption Value by Country (2019-2030)
6.3.2 United States Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
6.3.3 Canada Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
6.3.4 Mexico Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Enteric Disease Testing and Therapeutic Consumption Value by Type (2019-2030)
7.2 Europe Enteric Disease Testing and Therapeutic Consumption Value by Application (2019-2030)
7.3 Europe Enteric Disease Testing and Therapeutic Market Size by Country
7.3.1 Europe Enteric Disease Testing and Therapeutic Consumption Value by Country (2019-2030)
7.3.2 Germany Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
7.3.3 France Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
7.3.5 Russia Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
7.3.6 Italy Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Region
8.3.1 Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value by Region (2019-2030)
8.3.2 China Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
8.3.3 Japan Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
8.3.4 South Korea Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
8.3.5 India Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
8.3.7 Australia Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Enteric Disease Testing and Therapeutic Consumption Value by Type (2019-2030)
9.2 South America Enteric Disease Testing and Therapeutic Consumption Value by Application (2019-2030)
9.3 South America Enteric Disease Testing and Therapeutic Market Size by Country
9.3.1 South America Enteric Disease Testing and Therapeutic Consumption Value by Country (2019-2030)
9.3.2 Brazil Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
9.3.3 Argentina Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Enteric Disease Testing and Therapeutic Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Enteric Disease Testing and Therapeutic Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Country
10.3.1 Middle East & Africa Enteric Disease Testing and Therapeutic Consumption Value by Country (2019-2030)
10.3.2 Turkey Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
10.3.4 UAE Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Enteric Disease Testing and Therapeutic Market Drivers
11.2 Enteric Disease Testing and Therapeutic Market Restraints
11.3 Enteric Disease Testing and Therapeutic Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Enteric Disease Testing and Therapeutic Industry Chain
12.2 Enteric Disease Testing and Therapeutic Upstream Analysis
12.3 Enteric Disease Testing and Therapeutic Midstream Analysis
12.4 Enteric Disease Testing and Therapeutic Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Enteric Disease Testing and Therapeutic
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Enteric Disease Testing and Therapeutic by Type
1.3.1 Overview: Global Enteric Disease Testing and Therapeutic Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Enteric Disease Testing and Therapeutic Consumption Value Market Share by Type in 2023
1.3.3 Bacterial Disease
1.3.4 Viral Disease
1.3.5 Parasitic Disease
1.4 Global Enteric Disease Testing and Therapeutic Market by Application
1.4.1 Overview: Global Enteric Disease Testing and Therapeutic Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Specialty Clinic
1.4.4 Others
1.5 Global Enteric Disease Testing and Therapeutic Market Size & Forecast
1.6 Global Enteric Disease Testing and Therapeutic Market Size and Forecast by Region
1.6.1 Global Enteric Disease Testing and Therapeutic Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Enteric Disease Testing and Therapeutic Market Size by Region, (2019-2030)
1.6.3 North America Enteric Disease Testing and Therapeutic Market Size and Prospect (2019-2030)
1.6.4 Europe Enteric Disease Testing and Therapeutic Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size and Prospect (2019-2030)
1.6.6 South America Enteric Disease Testing and Therapeutic Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Enteric Disease Testing and Therapeutic Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Enteric Disease Testing and Therapeutic Product and Solutions
2.1.4 Abbott Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbott Recent Developments and Future Plans
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Enteric Disease Testing and Therapeutic Product and Solutions
2.2.4 GlaxoSmithKline Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GlaxoSmithKline Recent Developments and Future Plans
2.3 Becton Dickinson
2.3.1 Becton Dickinson Details
2.3.2 Becton Dickinson Major Business
2.3.3 Becton Dickinson Enteric Disease Testing and Therapeutic Product and Solutions
2.3.4 Becton Dickinson Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Becton Dickinson Recent Developments and Future Plans
2.4 bioMйrieux
2.4.1 bioMйrieux Details
2.4.2 bioMйrieux Major Business
2.4.3 bioMйrieux Enteric Disease Testing and Therapeutic Product and Solutions
2.4.4 bioMйrieux Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 bioMйrieux Recent Developments and Future Plans
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Enteric Disease Testing and Therapeutic Product and Solutions
2.5.4 Sanofi Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sanofi Recent Developments and Future Plans
2.6 Bayer Pharma
2.6.1 Bayer Pharma Details
2.6.2 Bayer Pharma Major Business
2.6.3 Bayer Pharma Enteric Disease Testing and Therapeutic Product and Solutions
2.6.4 Bayer Pharma Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bayer Pharma Recent Developments and Future Plans
2.7 Bio-Rad
2.7.1 Bio-Rad Details
2.7.2 Bio-Rad Major Business
2.7.3 Bio-Rad Enteric Disease Testing and Therapeutic Product and Solutions
2.7.4 Bio-Rad Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Bio-Rad Recent Developments and Future Plans
2.8 Quest Diagnostics
2.8.1 Quest Diagnostics Details
2.8.2 Quest Diagnostics Major Business
2.8.3 Quest Diagnostics Enteric Disease Testing and Therapeutic Product and Solutions
2.8.4 Quest Diagnostics Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Quest Diagnostics Recent Developments and Future Plans
2.9 Trinity Biotech
2.9.1 Trinity Biotech Details
2.9.2 Trinity Biotech Major Business
2.9.3 Trinity Biotech Enteric Disease Testing and Therapeutic Product and Solutions
2.9.4 Trinity Biotech Enteric Disease Testing and Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Trinity Biotech Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Enteric Disease Testing and Therapeutic Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Enteric Disease Testing and Therapeutic by Company Revenue
3.2.2 Top 3 Enteric Disease Testing and Therapeutic Players Market Share in 2023
3.2.3 Top 6 Enteric Disease Testing and Therapeutic Players Market Share in 2023
3.3 Enteric Disease Testing and Therapeutic Market: Overall Company Footprint Analysis
3.3.1 Enteric Disease Testing and Therapeutic Market: Region Footprint
3.3.2 Enteric Disease Testing and Therapeutic Market: Company Product Type Footprint
3.3.3 Enteric Disease Testing and Therapeutic Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Enteric Disease Testing and Therapeutic Consumption Value and Market Share by Type (2019-2024)
4.2 Global Enteric Disease Testing and Therapeutic Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Enteric Disease Testing and Therapeutic Consumption Value Market Share by Application (2019-2024)
5.2 Global Enteric Disease Testing and Therapeutic Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Enteric Disease Testing and Therapeutic Consumption Value by Type (2019-2030)
6.2 North America Enteric Disease Testing and Therapeutic Consumption Value by Application (2019-2030)
6.3 North America Enteric Disease Testing and Therapeutic Market Size by Country
6.3.1 North America Enteric Disease Testing and Therapeutic Consumption Value by Country (2019-2030)
6.3.2 United States Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
6.3.3 Canada Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
6.3.4 Mexico Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Enteric Disease Testing and Therapeutic Consumption Value by Type (2019-2030)
7.2 Europe Enteric Disease Testing and Therapeutic Consumption Value by Application (2019-2030)
7.3 Europe Enteric Disease Testing and Therapeutic Market Size by Country
7.3.1 Europe Enteric Disease Testing and Therapeutic Consumption Value by Country (2019-2030)
7.3.2 Germany Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
7.3.3 France Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
7.3.5 Russia Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
7.3.6 Italy Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Region
8.3.1 Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value by Region (2019-2030)
8.3.2 China Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
8.3.3 Japan Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
8.3.4 South Korea Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
8.3.5 India Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
8.3.7 Australia Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Enteric Disease Testing and Therapeutic Consumption Value by Type (2019-2030)
9.2 South America Enteric Disease Testing and Therapeutic Consumption Value by Application (2019-2030)
9.3 South America Enteric Disease Testing and Therapeutic Market Size by Country
9.3.1 South America Enteric Disease Testing and Therapeutic Consumption Value by Country (2019-2030)
9.3.2 Brazil Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
9.3.3 Argentina Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Enteric Disease Testing and Therapeutic Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Enteric Disease Testing and Therapeutic Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Country
10.3.1 Middle East & Africa Enteric Disease Testing and Therapeutic Consumption Value by Country (2019-2030)
10.3.2 Turkey Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
10.3.4 UAE Enteric Disease Testing and Therapeutic Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Enteric Disease Testing and Therapeutic Market Drivers
11.2 Enteric Disease Testing and Therapeutic Market Restraints
11.3 Enteric Disease Testing and Therapeutic Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Enteric Disease Testing and Therapeutic Industry Chain
12.2 Enteric Disease Testing and Therapeutic Upstream Analysis
12.3 Enteric Disease Testing and Therapeutic Midstream Analysis
12.4 Enteric Disease Testing and Therapeutic Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Enteric Disease Testing and Therapeutic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Enteric Disease Testing and Therapeutic Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Enteric Disease Testing and Therapeutic Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Enteric Disease Testing and Therapeutic Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Abbott Company Information, Head Office, and Major Competitors
Table 6. Abbott Major Business
Table 7. Abbott Enteric Disease Testing and Therapeutic Product and Solutions
Table 8. Abbott Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Abbott Recent Developments and Future Plans
Table 10. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 11. GlaxoSmithKline Major Business
Table 12. GlaxoSmithKline Enteric Disease Testing and Therapeutic Product and Solutions
Table 13. GlaxoSmithKline Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. GlaxoSmithKline Recent Developments and Future Plans
Table 15. Becton Dickinson Company Information, Head Office, and Major Competitors
Table 16. Becton Dickinson Major Business
Table 17. Becton Dickinson Enteric Disease Testing and Therapeutic Product and Solutions
Table 18. Becton Dickinson Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Becton Dickinson Recent Developments and Future Plans
Table 20. bioMйrieux Company Information, Head Office, and Major Competitors
Table 21. bioMйrieux Major Business
Table 22. bioMйrieux Enteric Disease Testing and Therapeutic Product and Solutions
Table 23. bioMйrieux Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. bioMйrieux Recent Developments and Future Plans
Table 25. Sanofi Company Information, Head Office, and Major Competitors
Table 26. Sanofi Major Business
Table 27. Sanofi Enteric Disease Testing and Therapeutic Product and Solutions
Table 28. Sanofi Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Sanofi Recent Developments and Future Plans
Table 30. Bayer Pharma Company Information, Head Office, and Major Competitors
Table 31. Bayer Pharma Major Business
Table 32. Bayer Pharma Enteric Disease Testing and Therapeutic Product and Solutions
Table 33. Bayer Pharma Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Bayer Pharma Recent Developments and Future Plans
Table 35. Bio-Rad Company Information, Head Office, and Major Competitors
Table 36. Bio-Rad Major Business
Table 37. Bio-Rad Enteric Disease Testing and Therapeutic Product and Solutions
Table 38. Bio-Rad Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Bio-Rad Recent Developments and Future Plans
Table 40. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 41. Quest Diagnostics Major Business
Table 42. Quest Diagnostics Enteric Disease Testing and Therapeutic Product and Solutions
Table 43. Quest Diagnostics Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Quest Diagnostics Recent Developments and Future Plans
Table 45. Trinity Biotech Company Information, Head Office, and Major Competitors
Table 46. Trinity Biotech Major Business
Table 47. Trinity Biotech Enteric Disease Testing and Therapeutic Product and Solutions
Table 48. Trinity Biotech Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Trinity Biotech Recent Developments and Future Plans
Table 50. Global Enteric Disease Testing and Therapeutic Revenue (USD Million) by Players (2019-2024)
Table 51. Global Enteric Disease Testing and Therapeutic Revenue Share by Players (2019-2024)
Table 52. Breakdown of Enteric Disease Testing and Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in Enteric Disease Testing and Therapeutic, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 54. Head Office of Key Enteric Disease Testing and Therapeutic Players
Table 55. Enteric Disease Testing and Therapeutic Market: Company Product Type Footprint
Table 56. Enteric Disease Testing and Therapeutic Market: Company Product Application Footprint
Table 57. Enteric Disease Testing and Therapeutic New Market Entrants and Barriers to Market Entry
Table 58. Enteric Disease Testing and Therapeutic Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Enteric Disease Testing and Therapeutic Consumption Value (USD Million) by Type (2019-2024)
Table 60. Global Enteric Disease Testing and Therapeutic Consumption Value Share by Type (2019-2024)
Table 61. Global Enteric Disease Testing and Therapeutic Consumption Value Forecast by Type (2025-2030)
Table 62. Global Enteric Disease Testing and Therapeutic Consumption Value by Application (2019-2024)
Table 63. Global Enteric Disease Testing and Therapeutic Consumption Value Forecast by Application (2025-2030)
Table 64. North America Enteric Disease Testing and Therapeutic Consumption Value by Type (2019-2024) & (USD Million)
Table 65. North America Enteric Disease Testing and Therapeutic Consumption Value by Type (2025-2030) & (USD Million)
Table 66. North America Enteric Disease Testing and Therapeutic Consumption Value by Application (2019-2024) & (USD Million)
Table 67. North America Enteric Disease Testing and Therapeutic Consumption Value by Application (2025-2030) & (USD Million)
Table 68. North America Enteric Disease Testing and Therapeutic Consumption Value by Country (2019-2024) & (USD Million)
Table 69. North America Enteric Disease Testing and Therapeutic Consumption Value by Country (2025-2030) & (USD Million)
Table 70. Europe Enteric Disease Testing and Therapeutic Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Europe Enteric Disease Testing and Therapeutic Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Europe Enteric Disease Testing and Therapeutic Consumption Value by Application (2019-2024) & (USD Million)
Table 73. Europe Enteric Disease Testing and Therapeutic Consumption Value by Application (2025-2030) & (USD Million)
Table 74. Europe Enteric Disease Testing and Therapeutic Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Enteric Disease Testing and Therapeutic Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value by Type (2019-2024) & (USD Million)
Table 77. Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value by Type (2025-2030) & (USD Million)
Table 78. Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value by Application (2019-2024) & (USD Million)
Table 79. Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value by Application (2025-2030) & (USD Million)
Table 80. Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value by Region (2019-2024) & (USD Million)
Table 81. Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value by Region (2025-2030) & (USD Million)
Table 82. South America Enteric Disease Testing and Therapeutic Consumption Value by Type (2019-2024) & (USD Million)
Table 83. South America Enteric Disease Testing and Therapeutic Consumption Value by Type (2025-2030) & (USD Million)
Table 84. South America Enteric Disease Testing and Therapeutic Consumption Value by Application (2019-2024) & (USD Million)
Table 85. South America Enteric Disease Testing and Therapeutic Consumption Value by Application (2025-2030) & (USD Million)
Table 86. South America Enteric Disease Testing and Therapeutic Consumption Value by Country (2019-2024) & (USD Million)
Table 87. South America Enteric Disease Testing and Therapeutic Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Middle East & Africa Enteric Disease Testing and Therapeutic Consumption Value by Type (2019-2024) & (USD Million)
Table 89. Middle East & Africa Enteric Disease Testing and Therapeutic Consumption Value by Type (2025-2030) & (USD Million)
Table 90. Middle East & Africa Enteric Disease Testing and Therapeutic Consumption Value by Application (2019-2024) & (USD Million)
Table 91. Middle East & Africa Enteric Disease Testing and Therapeutic Consumption Value by Application (2025-2030) & (USD Million)
Table 92. Middle East & Africa Enteric Disease Testing and Therapeutic Consumption Value by Country (2019-2024) & (USD Million)
Table 93. Middle East & Africa Enteric Disease Testing and Therapeutic Consumption Value by Country (2025-2030) & (USD Million)
Table 94. Enteric Disease Testing and Therapeutic Raw Material
Table 95. Key Suppliers of Enteric Disease Testing and Therapeutic Raw Materials
Table 1. Global Enteric Disease Testing and Therapeutic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Enteric Disease Testing and Therapeutic Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Enteric Disease Testing and Therapeutic Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Enteric Disease Testing and Therapeutic Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Abbott Company Information, Head Office, and Major Competitors
Table 6. Abbott Major Business
Table 7. Abbott Enteric Disease Testing and Therapeutic Product and Solutions
Table 8. Abbott Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Abbott Recent Developments and Future Plans
Table 10. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 11. GlaxoSmithKline Major Business
Table 12. GlaxoSmithKline Enteric Disease Testing and Therapeutic Product and Solutions
Table 13. GlaxoSmithKline Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. GlaxoSmithKline Recent Developments and Future Plans
Table 15. Becton Dickinson Company Information, Head Office, and Major Competitors
Table 16. Becton Dickinson Major Business
Table 17. Becton Dickinson Enteric Disease Testing and Therapeutic Product and Solutions
Table 18. Becton Dickinson Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Becton Dickinson Recent Developments and Future Plans
Table 20. bioMйrieux Company Information, Head Office, and Major Competitors
Table 21. bioMйrieux Major Business
Table 22. bioMйrieux Enteric Disease Testing and Therapeutic Product and Solutions
Table 23. bioMйrieux Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. bioMйrieux Recent Developments and Future Plans
Table 25. Sanofi Company Information, Head Office, and Major Competitors
Table 26. Sanofi Major Business
Table 27. Sanofi Enteric Disease Testing and Therapeutic Product and Solutions
Table 28. Sanofi Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Sanofi Recent Developments and Future Plans
Table 30. Bayer Pharma Company Information, Head Office, and Major Competitors
Table 31. Bayer Pharma Major Business
Table 32. Bayer Pharma Enteric Disease Testing and Therapeutic Product and Solutions
Table 33. Bayer Pharma Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Bayer Pharma Recent Developments and Future Plans
Table 35. Bio-Rad Company Information, Head Office, and Major Competitors
Table 36. Bio-Rad Major Business
Table 37. Bio-Rad Enteric Disease Testing and Therapeutic Product and Solutions
Table 38. Bio-Rad Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Bio-Rad Recent Developments and Future Plans
Table 40. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 41. Quest Diagnostics Major Business
Table 42. Quest Diagnostics Enteric Disease Testing and Therapeutic Product and Solutions
Table 43. Quest Diagnostics Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Quest Diagnostics Recent Developments and Future Plans
Table 45. Trinity Biotech Company Information, Head Office, and Major Competitors
Table 46. Trinity Biotech Major Business
Table 47. Trinity Biotech Enteric Disease Testing and Therapeutic Product and Solutions
Table 48. Trinity Biotech Enteric Disease Testing and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Trinity Biotech Recent Developments and Future Plans
Table 50. Global Enteric Disease Testing and Therapeutic Revenue (USD Million) by Players (2019-2024)
Table 51. Global Enteric Disease Testing and Therapeutic Revenue Share by Players (2019-2024)
Table 52. Breakdown of Enteric Disease Testing and Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in Enteric Disease Testing and Therapeutic, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 54. Head Office of Key Enteric Disease Testing and Therapeutic Players
Table 55. Enteric Disease Testing and Therapeutic Market: Company Product Type Footprint
Table 56. Enteric Disease Testing and Therapeutic Market: Company Product Application Footprint
Table 57. Enteric Disease Testing and Therapeutic New Market Entrants and Barriers to Market Entry
Table 58. Enteric Disease Testing and Therapeutic Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Enteric Disease Testing and Therapeutic Consumption Value (USD Million) by Type (2019-2024)
Table 60. Global Enteric Disease Testing and Therapeutic Consumption Value Share by Type (2019-2024)
Table 61. Global Enteric Disease Testing and Therapeutic Consumption Value Forecast by Type (2025-2030)
Table 62. Global Enteric Disease Testing and Therapeutic Consumption Value by Application (2019-2024)
Table 63. Global Enteric Disease Testing and Therapeutic Consumption Value Forecast by Application (2025-2030)
Table 64. North America Enteric Disease Testing and Therapeutic Consumption Value by Type (2019-2024) & (USD Million)
Table 65. North America Enteric Disease Testing and Therapeutic Consumption Value by Type (2025-2030) & (USD Million)
Table 66. North America Enteric Disease Testing and Therapeutic Consumption Value by Application (2019-2024) & (USD Million)
Table 67. North America Enteric Disease Testing and Therapeutic Consumption Value by Application (2025-2030) & (USD Million)
Table 68. North America Enteric Disease Testing and Therapeutic Consumption Value by Country (2019-2024) & (USD Million)
Table 69. North America Enteric Disease Testing and Therapeutic Consumption Value by Country (2025-2030) & (USD Million)
Table 70. Europe Enteric Disease Testing and Therapeutic Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Europe Enteric Disease Testing and Therapeutic Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Europe Enteric Disease Testing and Therapeutic Consumption Value by Application (2019-2024) & (USD Million)
Table 73. Europe Enteric Disease Testing and Therapeutic Consumption Value by Application (2025-2030) & (USD Million)
Table 74. Europe Enteric Disease Testing and Therapeutic Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Enteric Disease Testing and Therapeutic Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value by Type (2019-2024) & (USD Million)
Table 77. Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value by Type (2025-2030) & (USD Million)
Table 78. Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value by Application (2019-2024) & (USD Million)
Table 79. Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value by Application (2025-2030) & (USD Million)
Table 80. Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value by Region (2019-2024) & (USD Million)
Table 81. Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value by Region (2025-2030) & (USD Million)
Table 82. South America Enteric Disease Testing and Therapeutic Consumption Value by Type (2019-2024) & (USD Million)
Table 83. South America Enteric Disease Testing and Therapeutic Consumption Value by Type (2025-2030) & (USD Million)
Table 84. South America Enteric Disease Testing and Therapeutic Consumption Value by Application (2019-2024) & (USD Million)
Table 85. South America Enteric Disease Testing and Therapeutic Consumption Value by Application (2025-2030) & (USD Million)
Table 86. South America Enteric Disease Testing and Therapeutic Consumption Value by Country (2019-2024) & (USD Million)
Table 87. South America Enteric Disease Testing and Therapeutic Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Middle East & Africa Enteric Disease Testing and Therapeutic Consumption Value by Type (2019-2024) & (USD Million)
Table 89. Middle East & Africa Enteric Disease Testing and Therapeutic Consumption Value by Type (2025-2030) & (USD Million)
Table 90. Middle East & Africa Enteric Disease Testing and Therapeutic Consumption Value by Application (2019-2024) & (USD Million)
Table 91. Middle East & Africa Enteric Disease Testing and Therapeutic Consumption Value by Application (2025-2030) & (USD Million)
Table 92. Middle East & Africa Enteric Disease Testing and Therapeutic Consumption Value by Country (2019-2024) & (USD Million)
Table 93. Middle East & Africa Enteric Disease Testing and Therapeutic Consumption Value by Country (2025-2030) & (USD Million)
Table 94. Enteric Disease Testing and Therapeutic Raw Material
Table 95. Key Suppliers of Enteric Disease Testing and Therapeutic Raw Materials
LIST OF FIGURES
Figure 1. Enteric Disease Testing and Therapeutic Picture
Figure 2. Global Enteric Disease Testing and Therapeutic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Enteric Disease Testing and Therapeutic Consumption Value Market Share by Type in 2023
Figure 4. Bacterial Disease
Figure 5. Viral Disease
Figure 6. Parasitic Disease
Figure 7. Global Enteric Disease Testing and Therapeutic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Enteric Disease Testing and Therapeutic Consumption Value Market Share by Application in 2023
Figure 9. Hospital Picture
Figure 10. Specialty Clinic Picture
Figure 11. Others Picture
Figure 12. Global Enteric Disease Testing and Therapeutic Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Enteric Disease Testing and Therapeutic Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Enteric Disease Testing and Therapeutic Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Enteric Disease Testing and Therapeutic Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Enteric Disease Testing and Therapeutic Consumption Value Market Share by Region in 2023
Figure 17. North America Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Enteric Disease Testing and Therapeutic Revenue Share by Players in 2023
Figure 23. Enteric Disease Testing and Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Enteric Disease Testing and Therapeutic Market Share in 2023
Figure 25. Global Top 6 Players Enteric Disease Testing and Therapeutic Market Share in 2023
Figure 26. Global Enteric Disease Testing and Therapeutic Consumption Value Share by Type (2019-2024)
Figure 27. Global Enteric Disease Testing and Therapeutic Market Share Forecast by Type (2025-2030)
Figure 28. Global Enteric Disease Testing and Therapeutic Consumption Value Share by Application (2019-2024)
Figure 29. Global Enteric Disease Testing and Therapeutic Market Share Forecast by Application (2025-2030)
Figure 30. North America Enteric Disease Testing and Therapeutic Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Enteric Disease Testing and Therapeutic Consumption Value Market Share by Application (2019-2030)
Figure 32. North America Enteric Disease Testing and Therapeutic Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Enteric Disease Testing and Therapeutic Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Enteric Disease Testing and Therapeutic Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe Enteric Disease Testing and Therapeutic Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 40. France Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value Market Share by Region (2019-2030)
Figure 47. China Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 50. India Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Enteric Disease Testing and Therapeutic Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Enteric Disease Testing and Therapeutic Consumption Value Market Share by Application (2019-2030)
Figure 55. South America Enteric Disease Testing and Therapeutic Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Enteric Disease Testing and Therapeutic Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Enteric Disease Testing and Therapeutic Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa Enteric Disease Testing and Therapeutic Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 64. Enteric Disease Testing and Therapeutic Market Drivers
Figure 65. Enteric Disease Testing and Therapeutic Market Restraints
Figure 66. Enteric Disease Testing and Therapeutic Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Enteric Disease Testing and Therapeutic in 2023
Figure 69. Manufacturing Process Analysis of Enteric Disease Testing and Therapeutic
Figure 70. Enteric Disease Testing and Therapeutic Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Enteric Disease Testing and Therapeutic Picture
Figure 2. Global Enteric Disease Testing and Therapeutic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Enteric Disease Testing and Therapeutic Consumption Value Market Share by Type in 2023
Figure 4. Bacterial Disease
Figure 5. Viral Disease
Figure 6. Parasitic Disease
Figure 7. Global Enteric Disease Testing and Therapeutic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Enteric Disease Testing and Therapeutic Consumption Value Market Share by Application in 2023
Figure 9. Hospital Picture
Figure 10. Specialty Clinic Picture
Figure 11. Others Picture
Figure 12. Global Enteric Disease Testing and Therapeutic Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Enteric Disease Testing and Therapeutic Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Enteric Disease Testing and Therapeutic Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Enteric Disease Testing and Therapeutic Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Enteric Disease Testing and Therapeutic Consumption Value Market Share by Region in 2023
Figure 17. North America Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Enteric Disease Testing and Therapeutic Revenue Share by Players in 2023
Figure 23. Enteric Disease Testing and Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Enteric Disease Testing and Therapeutic Market Share in 2023
Figure 25. Global Top 6 Players Enteric Disease Testing and Therapeutic Market Share in 2023
Figure 26. Global Enteric Disease Testing and Therapeutic Consumption Value Share by Type (2019-2024)
Figure 27. Global Enteric Disease Testing and Therapeutic Market Share Forecast by Type (2025-2030)
Figure 28. Global Enteric Disease Testing and Therapeutic Consumption Value Share by Application (2019-2024)
Figure 29. Global Enteric Disease Testing and Therapeutic Market Share Forecast by Application (2025-2030)
Figure 30. North America Enteric Disease Testing and Therapeutic Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Enteric Disease Testing and Therapeutic Consumption Value Market Share by Application (2019-2030)
Figure 32. North America Enteric Disease Testing and Therapeutic Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Enteric Disease Testing and Therapeutic Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Enteric Disease Testing and Therapeutic Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe Enteric Disease Testing and Therapeutic Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 40. France Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific Enteric Disease Testing and Therapeutic Consumption Value Market Share by Region (2019-2030)
Figure 47. China Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 50. India Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Enteric Disease Testing and Therapeutic Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Enteric Disease Testing and Therapeutic Consumption Value Market Share by Application (2019-2030)
Figure 55. South America Enteric Disease Testing and Therapeutic Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Enteric Disease Testing and Therapeutic Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Enteric Disease Testing and Therapeutic Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa Enteric Disease Testing and Therapeutic Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Enteric Disease Testing and Therapeutic Consumption Value (2019-2030) & (USD Million)
Figure 64. Enteric Disease Testing and Therapeutic Market Drivers
Figure 65. Enteric Disease Testing and Therapeutic Market Restraints
Figure 66. Enteric Disease Testing and Therapeutic Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Enteric Disease Testing and Therapeutic in 2023
Figure 69. Manufacturing Process Analysis of Enteric Disease Testing and Therapeutic
Figure 70. Enteric Disease Testing and Therapeutic Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
